Combined with our previous results [12–14], our data indicate that MSCs in the tumour microenvironment can promote the proliferation of non-mucinous OC in vitro and in vivo through the PAF/PAFR signalling pathway. The gene discussed is PCLAF; the disease is neoplasm.